183 related articles for article (PubMed ID: 35346069)
1. Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.
Jia Z; Wang Y; Gao J; Zu G
BMC Gastroenterol; 2022 Mar; 22(1):142. PubMed ID: 35346069
[TBL] [Abstract][Full Text] [Related]
2. The Clinicopathological and Prognostic Significance of SOX9 Expression in Gastric Cancer: Meta-Analysis and TCGA Analysis.
Zu G; Gao J; Zhou T
Front Oncol; 2021; 11():668946. PubMed ID: 34568009
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.
Jia Z; Gao J; Wang Y; Zhou T; Zhang X; Zu G
Sci Rep; 2022 Oct; 12(1):16786. PubMed ID: 36202905
[TBL] [Abstract][Full Text] [Related]
4. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
8. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and Prognostic Value of USP22 Expression in Gastric Cancer: A Systematic Review and Meta-Analysis and Database Validation.
Wang Y; Jia Z; Gao J; Zhou T; Zhang X; Zu G
Front Surg; 2022; 9():920595. PubMed ID: 35784926
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis.
Wang Q; Chen H; Yang C; Liu Y; Li F; Zhang C
Medicine (Baltimore); 2022 Sep; 101(37):e30533. PubMed ID: 36123852
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
12. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C
Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
Tan G; Liu B
Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
[TBL] [Abstract][Full Text] [Related]
14. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
[TBL] [Abstract][Full Text] [Related]
15. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z
Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
17. PROX1 Is Associated with Cancer Progression and Prognosis in Gastric Cancer.
Ueta K; Otowa Y; Kakeji Y; Hirashima M
Anticancer Res; 2018 Nov; 38(11):6139-6145. PubMed ID: 30396930
[TBL] [Abstract][Full Text] [Related]
18. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
Ma X; Wang J; Zhao M; Huang H; Wu J
Oncol Lett; 2019 Jul; 18(1):465-471. PubMed ID: 31289518
[TBL] [Abstract][Full Text] [Related]
20. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.
Ramani P; Norton A; Somerville MS; May MT
J Neurooncol; 2012 Jul; 108(3):375-83. PubMed ID: 22382784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
